Table 1.
Patient Characteristics of EGFR, RET and ROS1
| All (n=73) |
EGFR (n=31) |
RET (n=25) |
ROS1 (n=17) |
p Value |
||
|---|---|---|---|---|---|---|
| EGFR vs RET/ROS1 |
RET vs ROS1 |
|||||
|
Age (years), median (range) |
61 (36, 89) | 61 (36, 87) | 59 (38, 84) | 61 (38, 89) | 0.80 | 0.58 |
| Gender, n(%) | ||||||
| F | 49 (67%) | 21 (68%) | 17 (68%) | 11 (65%) | 0.99 | 0.99 |
| M | 24 (33%) | 10 (32%) | 8 (32%) | 6 (35%) | ||
| Stage, n(%) | ||||||
| 1 | 1 (1%) | 0 (0%) | 1 (4%) | 0 (0%) | 0.95 | 0.90 |
| 2 | 5 (7%) | 2 (6%) | 2 (8%) | 1 (6%) | 0.99 (1 vs 2–4) | 0.99 (1 vs 2–4) |
| 3 | 10 (14%) | 5 (16%) | 2 (8%) | 3 (18%) | ||
| 4 | 57 (78%) | 24 (77%) | 20 (80%) | 13 (76%) | ||